A recently launched video series from the Biotechnology Innovation Organization (BIO) seeks to show how biotech may be able ...

In a report released yesterday, Myles Minter from William Blair maintained a Buy rating on Argenx Se. The company’s shares closed today at $591.99. Take advantage of TipRanks Premium at 50% off!

Arcturus Therapeutics Holdings Inc. annual income statement. View ARCT financial statements in full, including balance sheets and ratios.